MaxCyte Ownership | Who Owns MaxCyte?

Overview Forecast RevenueFinancials Chart Transcripts

MaxCyte Ownership Summary

MaxCyte is owned by 11.52% institutional investors, 1.77% insiders, and 86.70% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.27% of MXCT shares. RGI UK Listed Smaller Coms B Acc is the top mutual fund, with 3.09% of its assets in MaxCyte shares.

MXCT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	MaxCyte	11.52%	1.77%	86.70%
Sector	Healthcare Stocks	232.80%	10.63%	-143.43%
Industry	Medical Device Stocks	38.12%	10.22%	51.67%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	8.80M	8.27%	$6.18M
Blackrock	8.14M	7.82%	$31.92M
Capricorn fund managers	8.20M	7.70%	$5.76M
Vanguard group	5.54M	5.21%	$8.59M
Vitruvian partners llp	5.04M	4.74%	$3.54M
Morgan stanley	3.69M	3.47%	$2.59M
Mudita advisors llp	3.37M	3.17%	$2.37M
Axa investment managers	2.77M	2.61%	$4.38M
Bnp paribas asset management	2.77M	2.61%	$1.95M
Geode capital management	2.36M	2.22%	$1.66M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Vitruvian partners llp	5.04M	3.17%	$3.54M
River & mercantile asset management llp	1.97M	2.14%	$7.78M
Brooklands fund management	2.19M	1.73%	$1.54M
Capricorn fund managers	8.20M	0.90%	$5.76M
Peapod lane capital	1.33M	0.76%	$925.82K
Nano cap new millennium growth fund l p	1.00M	0.66%	$702.50K
Luminus management	1.15M	0.49%	$807.88K
Mudita advisors llp	3.37M	0.48%	$2.37M
Stonepine capital management	1.00M	0.28%	$705.78K
Cadian capital management, lp	1.72M	0.15%	$1.21M

Top Buyers

Holder	Shares	% Assets	Change
Capricorn fund managers	8.20M	0.90%	8.20M
Axa investment managers	2.77M	0.01%	2.77M
Brooklands fund management	2.19M	1.73%	2.19M
Peapod lane capital	1.33M	0.76%	1.33M
Renaissance	1.99M	0.00%	1.21M

Top Sellers

Holder	Shares	% Assets	Change
Mirabella financial services llp	-	-	-8.20M
Axa	-	-	-2.20M
Kennedy capital management	-	-	-2.11M
Cadian capital management, lp	1.72M	0.15%	-1.96M
Swedbank ab	-	-	-1.39M

New Positions

Holder	Shares	% Assets	Change	Value
Capricorn fund managers	8.20M	0.90%	8.20M	$5.76M
Axa investment managers	2.77M	0.01%	2.77M	$4.38M
Brooklands fund management	2.19M	1.73%	2.19M	$1.54M
Peapod lane capital	1.33M	0.76%	1.33M	$925.82K
Vanguard fiduciary trust	643.21K	0.00%	643.21K	$452.17K

Sold Out

Holder	Change
Capital performance advisors llp	-12.00
Nelson, van denburg & campbell wealth management group	-17.00
Kayne anderson rudnick investment management	-95.00
Clearstead advisors	-97.00
Physician wealth advisors	-202.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	21	-81.08%	12,253,063	-82.52%	11	0.27%	4	-91.84%	10	-75.61%
Sep 30, 2025	34	-70.69%	13,023,264	-81.74%	12	0.27%	14	-77.78%	12	-65.71%
Jun 30, 2025	114	-	71,273,845	-1.39%	66	1.44%	61	17.31%	35	-18.60%
Mar 31, 2025	6	-94.96%	11,761,193	-83.77%	11	0.23%	3	-95.38%	2	-93.33%
Dec 31, 2024	112	-6.67%	62,742,646	-8.73%	59	1.40%	61	-1.61%	27	-6.90%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
RGI UK Listed Smaller Coms B Acc	3.30M	3.09%	-
Vanguard US Total Market Shares ETF	2.92M	2.76%	-30.16K
AXA Framlington Health Fund - R Income	2.77M	2.59%	-
Vanguard Total Stock Mkt Idx Inv	2.74M	2.57%	-
Unicorn AIM VCT Ord	2.49M	2.32%	-
iShares Russell 2000 ETF	2.43M	2.27%	20.49K
Swedbank Robur USA A	1.36M	1.28%	-30.00K
IFSL Marlborough UK Micro Cap Gr A Acc	1.22M	1.14%	-135.00K
Vanguard Institutional Extnd Mkt Idx Tr	1.17M	1.09%	-
BlackRock Smaller Companies Ord	1.04M	0.99%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 17, 2026	Swirsky Douglas J	CHIEF FINANCIAL OFFICER	Sell	$8.27K
Jun 25, 2025	Hemrajani Rekha	-	Sell	$22.38K
Aug 13, 2025	Swirsky Douglas J	CHIEF FINANCIAL OFFICER	Buy	$64.50K
Aug 13, 2025	Masoud Maher	President and CEO	Buy	$102.92K
Aug 13, 2025	Erck Stanley C	-	Buy	$137.22K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	1
2025 Q3	5	-
2025 Q2	-	-
2025 Q1	-	5

MXCT Ownership FAQ

Who Owns MaxCyte?

MaxCyte shareholders are primarily institutional investors at 11.52%, followed by 1.77% insiders and 86.71% retail investors. The average institutional ownership in MaxCyte's industry, Medical Device Stocks, is 38.12%, which MaxCyte falls below.

Who owns the most shares of MaxCyte?

MaxCyte’s largest shareholders are Blackrock funding, inc. /de (8.8M shares, 8.27%), Blackrock (8.14M shares, 7.82%), and Capricorn fund managers (8.2M shares, 7.70%). Together, they hold 23.79% of MaxCyte’s total shares outstanding.

Does Blackrock own MaxCyte?

Yes, BlackRock owns 7.82% of MaxCyte, totaling 8.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 31.92M$. In the last quarter, BlackRock increased its holdings by 912.79K shares, a 12.63% change.

Who is MaxCyte’s biggest shareholder by percentage of total assets invested?

Vitruvian partners llp is MaxCyte’s biggest shareholder by percentage of total assets invested, with 3.17% of its assets in 5.04M MaxCyte shares, valued at 3.54M$.

Who is the top mutual fund holder of MaxCyte shares?

RGI UK Listed Smaller Coms B Acc is the top mutual fund holder of MaxCyte shares, with 3.09% of its total shares outstanding invested in 3.3M MaxCyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools